NFKB2 and hyperinsulinemic hypoglycemia, familial, 4: Single reports suggest an increased risk of severe COVID19 in patients with NFKB2 deficiency [9] and reports including a large number of patients with common variable immunodeficiency (CVID) suggested a higher fatality rate from SARS-CoV-2 infections among a subgroup [10, 11].